Sage Therapeutics Inc


Market Cap$681.26M

Compare Sage Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sage Therapeutics IncSage Therapeutics Inc-1.40%-71%11.8-
marketMarket Avg53.91.27%26%-1.2
HealthcareHealthcare Avg30.31.33%16%7.51.3

Target Price by Analysts

81.9% upsideSage Therapeutics Target Price DetailsTarget Price

Current Fair Value

82% upside

Undervalued by 82% based on the discounted cash flow analysis.

Share Statistics

Market cap$681.26 Million
Enterprise Value$-35,752,409.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-8.39
Outstanding Shares60,182,031
Avg 30 Day Volume1,220,066


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.35
Price to Sales11.78
Price to Book Ratio1.07
Enterprise Value to Revenue-0.39
Enterprise Value to EBIT0.07
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Sage Therapeutics Inc

CEO: Jeffrey Jonas